Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements

Scott M. Pearson, Jennifer M. Trujillo
  • Therapeutic Advances in Endocrinology and Metabolism, March 2018, SAGE Publications
  • DOI: 10.1177/2042018818760962
The author haven't yet claimed this publicationThe author haven't yet claimed this publication
Read Publication

http://dx.doi.org/10.1177/2042018818760962

In partnership with: